Financhill
Back

Nanobiotix SA 10K Form

Sell
29

NBTX
Nanobiotix SA

Last Price:
3.75
Seasonality Move:
1.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NBTX News And Ratings

See the #1 stock for the next 7 days that we like better than NBTX

NBTX Financial Statistics

Sales & Book Value

Annual Sales: $32.54M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.49
Price / Book: 0

Profitability

EPS (TTM): -0.79680
Net Income (TTM): $-36.04M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -44.94%

Nanobiotix SA Earnings Forecast

Key Nanobiotix SA Financial Ratios

  • The Research & Development expenses have been 127.74% of Revenue.
  • The Interest Expense is -20.11% of Operating Income.
  • The Net Earning history of NBTX is -132.08% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 4 years.

Nanobiotix SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NBTX
CUSIP: 63009J
Website: nanobiotix.com

Debt

Debt-to-Equity Ratio: -2.04
Current Ratio: 1.42
Quick Ratio: 1.38

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NBTX Technical Analysis vs Fundamental Analysis

Sell
29
Nanobiotix SA (NBTX) is a Sell

Is Nanobiotix SA a Buy or a Sell?

  • Nanobiotix SA stock is rated a Sell
    The current Nanobiotix SA [NBTX] share price is $3.79. The Score for NBTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.